Mutual Advisors, LLC - SPDR SER TR ownership

SPDR SER TR's ticker is SPYG and the CUSIP is 78464A409. A total of 297 filers reported holding SPDR SER TR in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
Mutual Advisors, LLC ownership history of SPDR SER TR
ValueSharesWeighting
Q3 2023$15,003,870
+383.0%
253,102
+397.1%
0.58%
+395.8%
Q2 2023$3,106,524
+71.5%
50,918
+55.6%
0.12%
+59.5%
Q1 2023$1,811,779
+6.5%
32,727
-2.5%
0.07%
-2.6%
Q4 2022$1,700,652
-0.7%
33,563
-1.8%
0.08%
-13.6%
Q3 2022$1,713,000
+27.4%
34,193
+32.9%
0.09%
-1.1%
Q2 2022$1,345,000
+13.4%
25,724
+43.6%
0.09%
+34.8%
Q1 2022$1,186,000
-5.6%
17,913
+3.4%
0.07%0.0%
Q4 2021$1,256,000
+20.3%
17,329
+6.3%
0.07%
+6.5%
Q3 2021$1,044,000
+27.0%
16,300
+24.9%
0.06%
+26.5%
Q2 2021$822,000
+11.8%
13,054
+0.1%
0.05%
-2.0%
Q1 2021$735,000
+19.9%
13,040
+17.6%
0.05%
+8.7%
Q4 2020$613,000
+11.5%
11,092
+1.1%
0.05%
-4.2%
Q3 2020$550,000
-17.0%
10,970
-25.7%
0.05%
-26.2%
Q2 2020$663,000
-86.7%
14,765
-89.4%
0.06%
-90.4%
Q1 2020$4,983,000
-41.0%
139,419
-30.8%
0.68%
-24.8%
Q4 2019$8,448,000
+22.8%
201,581
+14.0%
0.90%
-1.1%
Q3 2019$6,879,000
+23.6%
176,888
+23.1%
0.91%
+25.7%
Q2 2019$5,567,000
+107.0%
143,737
+98.9%
0.72%
+81.7%
Q1 2019$2,689,000
-32.3%
72,268
-40.9%
0.40%
-49.2%
Q4 2018$3,973,000
+129.0%
122,245
+169.5%
0.78%
+197.7%
Q3 2018$1,735,000
+278.8%
45,361
+248.0%
0.26%
+152.9%
Q2 2018$458,00013,0360.10%
Other shareholders
SPDR SER TR shareholders Q1 2019
NameSharesValueWeighting ↓
Buttonwood Financial Group, LLC 107,204$6,974,6625.08%
Michael S. Ryan, Inc. 67,717$4,405,6603.66%
Founders Capital Management 59,913$3,897,9232.83%
GoalVest Advisory LLC 98,108$6,382,9062.81%
Arden Trust Co 285,278$18,560,1962.72%
CGN Advisors LLC 250,372$16,289,2022.26%
WALLER FINANCIAL PLANNING GROUP, INC 71,095$4,625,4411.22%
JUNCTURE WEALTH STRATEGIES, LLC 18,735$1,218,8990.55%
WealthPLAN Partners, LLC 80,434$5,233,0370.54%
WealthPlan Investment Management, LLC 31,009$2,017,4220.32%
View complete list of SPDR SER TR shareholders